Alropan D 30mg/40mg Capsule SR
By Alropan-D
Rx
10 Capsule SR in a Strip

Composition
Domperidone(30mg) + Pantoprazole(40mg)

Manufacturer - Alrosa Pharmaceuticals Pvt Ltd
H.No. 976, Sector 7, Urban Estate Ambala City Ambala Ambala Hr 134003 India

Expires on or after
October, 2025

liver
Safety Advice - Liver When it comes to liver issues, it appears that Alropan D 30mg/40mg Capsule SR is generally considered safe for patients with liver disease. The available data indicates that there may not be a requirement for dose adjustment specifically for individuals with liver conditions. However, it is crucial to consult with your doctor before starting or continuing the use of Alropan D 30mg/40mg Capsule SR to ensure it is suitable for your liver health. Your doctor's guidance is essential in managing the medication effectively and safely.

kidney
Alropan D 30mg/40mg Capsule SR requires caution in kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
Caution is advised when drinking alcohol with Alropan D 30mg/40mg Capsule SR. Consult your doctor regarding alcohol consumption.

driving
When taking Alropan D 30mg/40mg Capsule SR, be cautious when driving as it may reduce alertness, cause vision disturbances, or lead to drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Alropan D 30mg/40mg Capsule SR may not be safe during pregnancy. Limited human studies show potential harm to the baby. Animal studies also indicate risks. Your doctor will assess benefits and risks before prescribing. Consult your doctor.

breastfeeding
During breastfeeding, it is advised to use Alropan D 30mg/40mg Capsule SR with caution. Breastfeeding should be paused until the mother's treatment is finished and the drug is eliminated from her body.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹88
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024